Clearside Biomedical's total assets for Q3 2024 were $29.16M, a decrease of -14.07% from the previous quarter. CLSD total liabilities were $63.95M for the fiscal quarter, a 2.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.